Deprenyl's neuroprotective action remains unresolved

Ann Neurol. 1996 Aug;40(2):266-7. doi: 10.1002/ana.410400226.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiparkinson Agents / adverse effects
  • Antiparkinson Agents / therapeutic use*
  • Humans
  • Levodopa / therapeutic use
  • Parkinson Disease / drug therapy*
  • Selegiline / adverse effects
  • Selegiline / therapeutic use*

Substances

  • Antiparkinson Agents
  • Selegiline
  • Levodopa